Abstract |
Among 2012 Docstyle survey respondents, 80% identified doxycycline as the appropriate treatment for Rocky Mountain spotted fever in patients ≥ 8 years old, but only 35% correctly chose doxycycline in patients <8 years old. These findings raise concerns about the higher pediatric case-fatality rate of Rocky Mountain spotted fever observed nationally. Targeted education efforts are needed.
|
Authors | Jillian Zientek, F Scott Dahlgren, Jennifer H McQuiston, Joanna Regan |
Journal | The Journal of pediatrics
(J Pediatr)
Vol. 164
Issue 2
Pg. 416-8
(Feb 2014)
ISSN: 1097-6833 [Electronic] United States |
PMID | 24252781
(Publication Type: Journal Article)
|
Copyright | Crown Copyright © 2014. Published by Mosby, Inc. All rights reserved. |
Chemical References |
- Anti-Bacterial Agents
- Doxycycline
|
Topics |
- Adult
- Aged
- Anti-Bacterial Agents
(adverse effects, therapeutic use)
- Child
- Doxycycline
(adverse effects, therapeutic use)
- Female
- Health Knowledge, Attitudes, Practice
- Health Personnel
(standards)
- Humans
- Male
- Middle Aged
- Rocky Mountain Spotted Fever
(drug therapy, mortality)
- Self Report
- Survival Rate
(trends)
- Tennessee
(epidemiology)
|